1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors
US7307079B2 · kind B2 · utility
6Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 30, 2003 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Nov 2, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to a group of novel triazine derivatives which are ligands for human adenosine-A3 receptors, as well as to pharmaceutical compositions containing a pharmacologically active amount of at least one of these compounds as an active ingredient. The invention relates to compounds of the general formula (1)wherein Y represents a group of the general formula (A), (B) or (C)and all other symbols have the meanings as given in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.